CannabisLink.ca - Current Affairs 2026

(2026) - Chronological (1767 items)

(All links open in new tab)

Oct 26, 2026	South African grower starts cultivation as the regulatory framework evolves In South Africa, licensed cannabis producers and the regulatory framework they answer to are still growing up together. For a couple in Cape Town, that meant three years with the same facility on their minds, from the first plans to a license that arrived in August 2026, after a process that started in December 2024 and took a little more than a year and a half to complete. "One of the main challenges was the lack of clear guidance on certain processes and expected turnaround times. This made planning more difficult, but we kept working through the requirements, and our focus was to bring the right expertise into the business as we were adapting," says Kim Praizovic, who co-founded CannaGrit with her husband.
Oct 26, 2026	Can Tourists Legally Buy Marijuana? Cannabis Laws Across All 50 States Travelers planning trips across the United States have a new resource to help navigate marijuana laws, with a recently released guide outlining where visitors can legally purchase cannabis and what restrictions apply in each state. Alexis 420, a directory of licensed cannabis dispensaries, has published a 50-state cannabis travel guide covering purchasing requirements, identification rules, taxes, and restrictions impacting out-of-state visitors.
Oct 26, 2026	From Endometriosis to Back Pain: The Medical Cannabis Trials to Watch in 2026 Could CBD help the one in ten women living with the excruciating pain caused by endometriosis? Could it ease the nerve symptoms that persist after chemotherapy? And how does a cannabis-based medicine compare with opioid painkillers? These questions are driving clinical research across the UK and Europe, with some programmes recruiting patients and others already producing results. In Scotland, two studies are investigating the same CBD formulation for different conditions.
Oct 26, 2026	Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program EDMONTON, AB, Oct. 26, 2026 /PRNewswire/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (ACB) (ACB), the Canadian-based leading global medical cannabis company, today shared that the application made by Curaleaf Holdings, Inc. ("Curaleaf") (CURA) (OTCQX: CURLF) to halt Aurora's at-the-market ("ATM") program was dismissed by the Alberta Securities Commission. This positive result supports Aurora's view that Curaleaf's actions were simply to distract shareholders from the fundamental issue before them: Curaleaf's hostile bid significantly undervalues Aurora and seeks to acquire Aurora's cash, unique EU-GMP assets, global growth platform and future upside at a discount.
Oct 26, 2026	Legal Medical Cannabis Means Better, Not Weaker, Health Protection Germany has, without question, the most progressive regulation of medical cannabis in the EU. Yet, the current federal government’s Ministry of Health, led by the CDU, wants to significantly restrict telemedical access to medical cannabis and specifically flowers, citing abuse. On closer inspection, there is still no supporting data or evidence for this.
Oct 26, 2026	‘They buy because it’s easy’: Legal shops want more than enforcement to fight illegal pot Though the Ford government says it’s planning to introduce new measures to crack down on illicit cannabis sales, legal retailers are questioning why it took eight years following legalization for enforcement tools to be bolstered. Several legal sellers told Global News they want Ontario to take the new rules a step further, by allowing the legal market to innovate and modernize cannabis sales by lifting some restrictions on how and where pot can be sold.
Oct 25, 2026	Polish Study Finds CBD To Be Beneficial For Post-Exercise Recovery Sports and athletics have been the focus of anti-cannabis propaganda for decades. Professional athletes are prominent in societies worldwide, so it’s no coincidence that anti-cannabis campaigns have incorporated professional leagues and athletes. Those anti-cannabis campaigns were based on the false premise that cannabis use is always bad, including cannabis use by professional and amateur athletes. Thankfully, many professional sports leagues have now abandoned testing for cannabis. Furthermore, cannabis research is establishing that cannabis can be beneficial for athletes. A recent example is a study led by researchers in Poland who examined the efficacy of cannabidiol (CBD) for post-exercise recovery. The study’s findings were published in the International Medical Journal and initially reported by Marijuana Moment.
Oct 25, 2026	Your body makes its own cannabis-like chemicals as you run, and neuroscience research finds they keep rising all the way to the marathon finish line, a possible clue to the runner’s high A long run appears to keep the body’s own cannabis-like chemical messengers active for hours. New research published in BMC Medicine indicates that one of these compounds, anandamide, climbs steadily during a marathon and stays elevated 45 minutes after the finish, and that levels are also higher after ultramarathons of up to 230 kilometers. These chemical changes occurred alongside shifts in mood, such as reduced anxiety after running, although the study did not test whether one caused the other.
Oct 24, 2026	Cannabis drinks boom sparks rift in US alcohol industry Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://help.ft.com/faq/gifting-and-sharing-an-article/what-is-a-gift-article/. https://www.ft.com/content/a4d00561-9309-427d-a5b7-556c2b4a74e8?syn-25a6b1a6=1 The rapid rise of THC-infused beverages has put US alcohol producers at odds with wholesalers and drinks retailers, as a growing number of consumers turn their backs on booze for a mellower high. Struggling brewers and distillers, mindful of the threat of an emerging competitor, have been calling for tough regulation of drinks containing THC, the primary psychoactive compound in cannabis. However, drinks distributors and retailers are pushing for forthcoming restrictions on the beverages to be overturned for fear of losing sales.
Oct 24, 2026	DEA Judge Denies Marijuana Rescheduling Opponents’ Request To Reopen Hearing For More Testimony, But Allows New Briefs A Drug Enforcement Administration (DEA) judge has rejected marijuana rescheduling opponents’ request to reopen an ongoing hearing on the Trump administration’s proposed reform for a new round of testimony and document discovery—but he is allowing a federal watchdog report that found there are “gaps” in the government’s process for evaluating controlled substances to be entered into the record and is inviting parties to submit additional briefs about it.
Oct 23, 2026	Gene-Edited Cannabis Is Already Here. Who Gets to Own It? F1 seed, triploids, genomic testing and gene editing are changing cannabis from the breeding tent to the corporate laboratory. The tools are shared. Access and control of the genetic library are not. Jorge Cervantes and his co-authors separate the promises from the proof.
Oct 23, 2026	Canada Cannabis Sales Reach New High in August 2026 Canada’s cannabis sales reached a new high in August 2026, totalling $520.4 million. Dried flower sales have also slightly rebounded in terms of units sold, while cannabis edibles increased and extracts declined. The new preliminary figures show national cannabis sales up about 3% year-over-year from $503.1 million in August 2025. Statistics Canada routinely updates its sales figures over time as new data comes in. As a result, July 2026 sales figures have been adjusted from $503.2 million to $515.8 million, a 3% increase.
Oct 23, 2026	How Low Can It Go: What You Need to Know About Cannabis Price Compression What Is Cannabis Price Compression? It's when retail prices plummet. This has happened in most legal states so far. Competitors who sell pretty much the same products due to lack of interstate commerce under federal law begin to drop prices to gain an edge and others eventually follow. It's also a response to illegal sales of cannabis products, which are usually cheaper than legal ones. For instance, in Massachessetts, which borders New York, the average price of flower is $14 per eight and $80-$150 per ounce. In New York, similar products go for $33 per eighth and $170-$320 per ounce. In Califonia, ounces sell for as low as $60. These are all big drops from when the legal markets opened. New York retailers are hoping prices will stay relatively high, unlike in most of the legal states
Oct 23, 2026	Israel Names Four Canadian Cannabis Companies for Anti-Dumping Investigation srael’s Commissioner for Trade Levies at the Ministry of Economy and Industry says it will investigate four Canadian cannabis companies in its latest probe into accusations of “product dumping.” In an October 22 announcement, the Commissioner named four companies: GrowCo, Cielo Verde Quebec Inc., 2323414 Alberta Ltd., and Koots Canna Ltd., which it identifies as being responsible for most of the cannabis being exported from Canada into Israel’s medical cannabis market.
Oct 23, 2026	Prominent Virginia senator charged over allegations she ran criminal cannabis scheme Federal prosecutors arrested a prominent Virginia lawmaker on Thursday over allegations she oversaw a criminal cannabis enterprise. Lucas and her alleged co-conspirators are charged with obtaining and illegally distributing large amounts of illegal cannabis. The government has also accused her of using her political influence to benefit herself and her family.
Oct 22, 2026	Survey: German Patients Overwhelmingly Prefer Cannabis From Pharmacies A survey of 7,913 German medicinal cannabis patients, almost 90% of whom have experience with both the unregulated and regulated markets, found that an overwhelming majority of them prefer making their medical cannabis purchases from pharmacies. Bloomwell Group GmbH, one of Europe’s leading medical cannabis companies, conducted the survey.
Oct 22, 2026	Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros The Canadian brand Cronos has finalized the ’Full acquisition of CanAdelaar, one of the largest licensed cannabis producers in the Netherlands, for a base price of 57.5 million euros. This acquisition establishes Cronos as a leader in the Dutch cannabis regulatory landscape and strengthens its presence in Europe.
Oct 22, 2026	Sorry Washington, You Can’t Beat the Gray Market Governments think they can eliminate demand by banning supply. That misunderstands how gray and black markets operate. Texas has spent decades prosecuting marijuana possession. Now, in Austin, someone carrying certain delta-8 THC gummies can face a felony charge, while possession of a small amount of marijuana is generally treated as a lower enforcement priority.
Oct 22, 2026	DEA Judge Denies Marijuana Rescheduling Opponents’ Request To Reopen Hearing For More Testimony, But Allows New Briefs A Drug Enforcement Administration (DEA) judge has rejected marijuana rescheduling opponents’ request to reopen an ongoing hearing on the Trump administration’s proposed reform for a new round of testimony and document discovery—but he is allowing a federal watchdog report that found there are “gaps” in the government’s process for evaluating controlled substances to be entered into the record and is inviting parties to submit additional briefs about it.
Oct 22, 2026	Hemp: The Council of the EU Takes a Stand on New Production and Marketing Rules The Council of the European Union has agreed on a negotiating position that could redefine the legal framework for industrial hemp at the European level. Whether it involves recognizing more parts of the cannabis plant Whether it is treating cannabis as an agricultural product or harmonizing THC requirements, the proposed changes represent a significant step forward for the sector, without, however, eliminating current national restrictions and regulatory uncertainty.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89